natgillin/translations-raw huggingface dataset:
Cherokee County
okrožje Brown
Crawford County
okrožje Hutchinson
Judith Basin County
okrožje Kingsbury
Fergus County
okrožje Lake
Dickey County
okrožje McCook
La Moure County
okrožje Mcpherson
Kingsbury County
okrožje Jefferson
Lake County
okrožje Chippewa
McCook County
okrožje Juneau
McPherson County
okrožje Buena Vista
Minnehaha County
okrožje Calhoun
Moody County
okrožje Clay
Roberts County
okrožje Dickinson
Spink County
okrožje Emmet
Yankton County
okrožje Hamilton
Jefferson County
okrožje Hardin
Chippewa County
okrožje Humboldt
Juneau County
okrožje Ida
Buena Vista County
okrožje Kossuth
Calhoun County
okrožje Lyon
Clay County
okrožje O'Brien
Dickinson County
okrožje Osceola
Emmet County
okrožje Palo Alto
Hamilton County
okrožje Plymouth
Hardin County
okrožje Sac
Humboldt County
okrožje Sioux
IDA County
okrožje Webster
Kossuth County
okrožje Woodbury
Lyon County
okrožje Wright
O'Brien County
okrožje Adair
Osceola County
okrožje Guthrie
Palo Alto County
okrožje Madison
Plymouth County
okrožje Whitley
Sac County
okrožje Dakota
Sioux County
okrožje Dixon
Webster County
okrožje Thurston
Woodbury County
okrožje Wayne
Wright County
okrožje Pocahontas
Adair County
US- 2.1
Commission Implementing Regulation (EU) 2015/1885
Izvedbena uredba Komisije (EU) 2015/1885
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-D, acibenzolar-s-methyl, amitrole, bentazone, cyhalofop butyl, diquat, esfenvalerate, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), glyphosate, iprovalicarb, isoproturon, lambda-cyhalothrin, metalaxyl-M, metsulfuron methyl, picolinafen, prosulfuron, pymetrozine, pyraflufen-ethyl, thiabendazole, thifensulfuron-methyl and triasulfuron
o spremembi Izvedbene Uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve za aktivne snovi 2,4-D, acibenzolar-s-metil, amitrol, bentazon, cihalofop butil, dikvat, esfenvalerat, famoksadon, flumioksazin, DPX KE 459 (flupirsulfuron-metil), glifosat, iprovalikarb, izoproturon, lambda-cihalotrin, metalaksil-M, metsulfuron metil, pikolinafen, prosulfuron, pimetrozin, piraflufen-etil, tiabendazol, tifensulfuron-metil in triasulfuron
The approvals of the active substances 2,4-D, acibenzolar-s-methyl, amitrole, bentazone, cyhalofop butyl, diquat, esfenvalerate, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), glyphosate, iprovalicarb, isoproturon, lambda-cyhalothrin, metalaxyl-M, metsulfuron methyl, picolinafen, prosulfuron, pymetrozine, pyraflufen-ethyl, thiabendazole, thifensulfuron-methyl and triasulfuron will expire on 31 December 2015.
Odobritve aktivnih snovi 2,4-D, acibenzolar-s-metil, amitrol, bentazon, cihalofop butil, dikvat, esfenvalerat, famoksadon, flumioksazin, DPX KE 459 (flupirsulfuron-metil), glifosat, iprovalikarb, izoproturon, lambda-cihalotrin, metalaksil-M, metsulfuron metil, pikolinafen, prosulfuron, pimetrozin, piraflufen-etil, tiabendazol, tifensulfuron-metil in triasulfuron bodo potekle 31. decembra 2015.
Applications for the renewal of the inclusion of those substances in Annex I to Council Directive 91/414/EEC [3] were submitted in accordance with Article 4 of Commission Regulation (EU) No 1141/2010 [4].
Zahtevek za obnovitev vključitve navedenih snovi v Prilogo I k Direktivi Sveta 91/414/EGS [3] je bil vložen v skladu s členom 4 Uredbe Komisije (EU) št. 1141/2010 [4].
Due to the fact that the assessment of the substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal.
Ker se je ocenjevanje snovi zavleklo iz razlogov, na katere vlagatelji ne morejo vplivati, obstaja možnost, da bo odobritev potekla pred sprejetjem sklepa o njihovi obnovitvi.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
Glede na cilj prvega odstavka člena 17 Uredbe (ES) št. 1107/2009 za primere, ko Komisija sprejme uredbo, da se odobritev aktivne snovi iz Priloge k tej uredbi ne obnovi, ker merila za odobritev niso izpolnjena, Komisija določi isti datum prenehanja odobritve kot pred to uredbo ali na dan začetka veljavnosti uredbe o neobnovitvi odobritve aktivne snovi, kar je pozneje.
in the sixth column, expiration of approval, of row 7, Metsulfuron methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 7 se za metsulfuron metil datum veljavnosti registracije „31. december 2015“ nadomesti z „30. junij 2016“;
in the sixth column, expiration of approval, of row 9, Triasulfuron, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 9 se za triasulfuron datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 10, Esfenvalerate, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 10 se za esfenvalerat datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 11, Bentazone, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 11 se za bentazon datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 12, Lambda-cyhalothrin, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 12 se za lambda-cihalotrin datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 14, Amitrole, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 14 se za amitrol datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 15, Diquat, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 15 se za dikvat datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 17, Thiabendazole, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 17 se za tiabendazol datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 19, DPX KE 459 (flupyrsulfuron-methyl), the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 19 se za DPX KE 459 (flupirsulfuron-metil) datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 20, Acibenzolar-s-methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 20 se za acibenzolar-s-metil datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 23, Pymetrozine, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 23 se za pimetrozin datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 24, Pyraflufen-ethyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 24 se za piraflufen-etil datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 25, Glyphosate, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 25 se za glifosat datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 26, Thifensulfuron-methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 26 se za tifensulfuron-metil datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 27, 2,4-D, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 27 se za 2,4-D datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 28, Isoproturon, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 28 se za izoproturon datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 30, Iprovalicarb, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 30 se za iprovalikarb datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 31, Prosulfuron, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 31 se za prosulfuron datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 34, Cyhalofop butyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 34 se za cihalofop butil datum veljavnosti registracije „31. december 2015“ nadomesti z „30. junij 2016“;
in the sixth column, expiration of approval, of row 35, Famoxadone, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 35 se za famoksadon datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 37 se za metalaksil-M datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 38, Picolinafen, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
v šestem stolpcu vrstice 38 se za pikolinafen datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“;
in the sixth column, expiration of approval, of row 39, Flumioxazine, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’.
v šestem stolpcu vrstice 39 se za flumioksazin datum veljavnosti registracije „31. december 2015“ nadomesti s „30. junij 2016“.
Following an application from Specialised Nutrition Europe (formerly European Dietetic Food Industry Association), submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to ‘non-digestible oligo- and polysaccharides including galacto-oligosaccharides, oligofructose, polyfructose and inulin' and 'increase in calcium absorption’ (Question No EFSA-Q-2008-140 [2]).
Družba Specialised Nutrition Europe (prej European Dietetic Food Industry Association) je v skladu s členom 14(1)(b) Uredbe (ES) št. 1924/2006 predložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z neprebavljivimi oligo- in polisaharidi, vključno z galakto-oligosaharidi, oligofruktozo, polifruktozo in inulinom, ter povečanjem absorpcije kalcija (vprašanje št.
The claim proposed by the applicant was worded, inter alia, as follows: ‘With non-digestible oligo- and/or polysaccharides to stimulate calcium absorption’.
EFSA-Q-2008-140 [2]).
On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 19 November 2014, that a cause and effect relationship cannot be established between the consumption of ‘non-digestible oligo- and polysaccharides including galacto-oligosaccharides, oligofructose, polyfructose and inulin’ and a beneficial physiological effect.
Vlagatelj je med drugim predlagal naslednjo trditev: „Neprebavljivi oligo- in/ali polisaharidi stimulirajo absorpcijo kalcija.“
In particular, the Authority considered that the food constituents ‘non-digestible oligo- and polysaccharides including galacto-oligosaccharides, oligofructose, polyfructose and inulin’ were not sufficiently characterised.
Agencija je na podlagi predloženih podatkov v mnenju, ki so ga Komisija in države članice prejele 19. novembra 2014, ugotovila, da vzročno-posledične povezave med uživanjem neprebavljivih oligo- in polisaharidov, vključno z galakto-oligosaharidi, oligofruktozo, polifruktozo in inulinom, ter koristnim fiziološkim učinkom ni mogoče utemeljiti.
Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.
Agencija je zlasti ugotovila, da živilske sestavine, kot so neprebavljivi oligo- in polisaharidi, vključno z galakto-oligosaharidi, oligofruktozo, polifruktozo in inulinom, niso bile zadostno utemeljene.
Following an application from Specialised Nutrition Europe, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to beta-galactosidase from Streptococcus thermophilus and reduction of gastrointestinal discomfort (Question No EFSA-Q-2008-148 [3]).
Ker zdravstvena trditev ne izpolnjuje zahtev iz Uredbe (ES) št. 1924/2006, se ne sme odobriti.
The claim proposed by the applicant was worded, inter alia, as follows: ‘Lactase for comfortable digestion’.
Družba Specialised Nutrition Europe je v skladu s členom 14(1)(b) Uredbe (ES) št. 1924/2006 predložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z vplivi beta-galaktozidaze iz Streptococcus thermophilus na zmanjšanje prebavnih motenj (vprašanje št.
On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 9 October 2014, that a cause and effect relationship had not been established between the consumption of beta-galactosidase, which is produced by Streptococcus thermophilus (subsequently inactivated) during fermentation of an infant formula, and reduction of gastrointestinal discomfort.
EFSA-Q-2008-148 [3]).
Following an application from Specialised Nutrition Europe, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to prunes and contribution to normal bowel function (Question No EFSA-Q-2008-193 [4]).
Vlagatelj je med drugim predlagal naslednjo trditev: „Laktaza za lažjo prebavo“.
The claim proposed by the applicant was worded, inter alia, as follows: ‘dried plums/prunes can contribute to normal bowel function’.
Agencija je na podlagi predloženih podatkov v mnenju, ki so ga Komisija in države članice prejele 9. oktobra 2014, ugotovila, da vzročno-posledična povezava med uživanjem beta-galaktozidaze, ki jo proizvaja Streptococcus thermophilus (naknadno inaktiviran) med fermentacijo, v formuli za dojenčke in zmanjšanjem prebavnih motenj ni bila utemeljena.
On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 19 November 2014, that a cause and effect relationship had not been established between the consumption of prunes and contribution to normal bowel function without the occurrence of diarrhoea for infants and young children from 6 months to 3 years of age.
Družba Specialised Nutrition Europe je v skladu s členom 14(1)(b) Uredbe (ES) št. 1924/2006 predložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z vplivi suhih sliv na normalno delovanje črevesja (vprašanje št.
In particular, the Authority noted that no studies investigating the effect of prunes on bowel function in infants and young children were provided by the applicant.
EFSA-Q-2008-193 [4]).
Accordingly, as the health claims listed in the Annex to this Regulation fulfil those conditions, the transitional period laid down in Article 28(6) of Regulation (EC) No 1924/2006 should apply.
Agencija je na podlagi predloženih podatkov v mnenju, ki so ga Komisija in države članice prejele 19. novembra 2014, ugotovila, da vzročno-posledična povezava med uživanjem suhih sliv in prispevanjem k normalnemu delovanju črevesja brez pojava driske pri dojenčkih in majhnih otrocih (od šest mesecev do treh let starosti) ni bila utemeljena.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
Agencija je zlasti ugotovila, da vlagatelj ni predložil nobenih študij o vplivu suhih sliv na delovanje črevesja pri dojenčkih in majhnih otrocih.
However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation may continue to be used for a maximum period of 6 months after the entry into force of this Regulation.
Zdravstvene trditve iz Priloge k tej uredbi se ne uvrstijo na seznam dovoljenih trditev Unije v skladu s členom 14(1) Uredbe (ES) št. 1924/2006.
Done at Brussels, 20 October 2015.
Ta uredba je v celoti zavezujoča in se neposredno uporablja v vseh državah članicah.
For the Commission
V Bruslju, 20. oktobra 2015
EFSA Journal 2014;12(11):3889.
UL L 404, 30.12.2006, str. 9.
EFSA Journal 2014;12(10):3841.
EFSA Journal 2014; 12(11): 3889.
EFSA Journal 2014;12(11):3892.
EFSA Journal 2014; 12(10): 3841.
ANNEX
EFSA Journal 2014; 12(11): 3892.
Article 14(1)(b) health claim referring to children's development and health
Referenčno mnenje Agencije za varnost hrane
Non-digestible oligo- and polysaccharides including galacto-oligosaccharides, oligofructose, polyfructose and inulin
Zdravstvena trditev po členu 14(1)(b), ki se nanaša na razvoj in zdravje otrok
With non-digestible oligo- and/or polysaccharides to stimulate calcium absorption
neprebavljivi oligo- in polisaharidi, vključno z galakto-oligosaharidi, oligofruktozo, polifruktozo in inulinom
Beta-galactosidase from Streptococcus thermophilus
Neprebavljivi oligo- in/ali polisaharidi stimulirajo absorpcijo kalcija.
Lactase for comfortable digestion
beta-galaktozidaza iz Streptococcus thermophilus
Prunes
Laktaza za lažjo prebavo.
Dried plums/prunes can contribute to normal bowel function
suhe slive
In accordance with Article 28(6) of Regulation (EC) No 1924/2006, health claims referred to in Article 14(1)(b) of that Regulation and not authorised by a decision pursuant to Article 17(3) of that Regulation may continue to be used for 6 months after the adoption of that decision, provided that the application for authorisation was made before 19 January 2008.
Suhe slive lahko prispevajo k normalnemu delovanju črevesja.
Commission Implementing Regulation (EU) 2015/1887
Izvedbena uredba Komisije (EU) 2015/1887
Commission Implementing Regulation (EU) 2015/1888
Izvedbena uredba Komisije (EU) 2015/1888
fixing the allocation coefficient to be applied to the quantities on which applications for import licences and applications for import rights lodged from 1 to 7 October 2015 are based and establishing the quantities to be added to the quantity fixed for the sub-period from 1 April to 30 June 2016 under the tariff quotas opened by Regulation (EC) No 616/2007 for poultrymeat
o določitvi koeficienta dodelitve, ki se bo uporabil za količine v zahtevkih za uvozna dovoljenja in zahtevkih za uvozne pravice, vloženih od 1. do 7. oktobra 2015, in določitvi količin, ki se bodo dodale količini, določeni za podobdobje od 1. aprila do 30. junija 2016 v okviru tarifnih kvot, ki so z Uredbo (ES) št. 616/2007 odprte v sektorju za perutnino
The quantities on which applications for import licences lodged from 1 to 7 October 2015 for the sub-period from 1 January to 31 March 2016 are based relate, for some quotas, to quantities exceeding those available.
Količine v zahtevkih za uvozna dovoljenja, ki so bili vloženi od 1. do 7. oktobra 2015 za podobdobje od 1. januarja do 31. marca 2016, so za nekatere kvote višje od razpoložljivih količin.
The quantities on which applications for import rights lodged from to 1 to 7 October 2015 for the sub-period from 1 January to 31 March 2016 are based relate, for some quotas, to quantities exceeding those available.
Količine v zahtevkih za uvozne pravice, ki so bili vloženi od 1. do 7. oktobra 2015 za podobdobje od 1. januarja do 31. marca 2016, so za nekatere kvote višje od razpoložljivih količin.
The quantities on which applications for import licences and import rights lodged from 1 to 7 October 2015 for the sub-period from 1 January to 31 March 2016 are based relate, for some quotas, to quantities less than those available.
Količine v zahtevkih za uvozna dovoljenja in zahtevkih za uvozne pravice, vloženih od 1. do 7. oktobra 2015 za podobdobje od 1. januarja do 31. marca 2016, so za nekatere kvote nižje od razpoložljivih količin.
The quantities on which applications for import licences lodged pursuant to Regulation (EC) No 616/2007 for the sub-period from 1 January to 31 March 2016 are based shall be multiplied by the allocation coefficient set out in part A of the Annex hereto.
Količine v zahtevkih za uvozna dovoljenja, vloženih v skladu z Uredbo (ES) št. 616/2007 za podobdobje od 1. januarja do 31. marca 2016, se pomnožijo s koeficientom dodelitve iz dela A Priloge k tej uredbi.
The quantities for which applications for import licences have not been lodged pursuant to Regulation (EC) No 616/2007, to be added to the sub-period from 1 April to 30 June 2016, are set out in part A of the Annex hereto.
Količine, za katere zahtevki za uvozna dovoljenja niso bili predloženi v skladu z Uredbo (ES) št. 616/2007 in ki jih je treba dodati količinam za podobdobje od 1. aprila do 30. junija 2016, so navedene v delu A Priloge k tej uredbi.
The quantities on which applications for import rights lodged pursuant to Regulation (EC) No 616/2007 for the sub-period from 1 January to 31 March 2016 are based shall be multiplied by the allocation coefficient set out in part B of the Annex hereto.
Količine v zahtevkih za uvozne pravice, vloženih v skladu z Uredbo (ES) št. 616/2007 za podobdobje od 1. januarja do 31. marca 2016, se pomnožijo s koeficientom dodelitve iz dela B Priloge k tej uredbi.
The quantities for which applications for import rights have not been lodged pursuant to Regulation (EC) No 616/2007, to be added to the sub-period from 1 April to 30 June 2016, are set out in part B of the Annex hereto.
Količine, za katere zahtevki za uvozne pravice niso bili predloženi v skladu z Uredbo (ES) št. 616/2007 in ki jih je treba dodati količinam za podobdobje od 1. aprila do 30. junija 2016, so navedene v delu B Priloge k tej uredbi.
Allocation coefficient — applications lodged for the sub-period from 1 January to 31 March 2016
Koeficient dodelitve – zahtevki, vloženi za podobdobje od 1. januarja do 31. marca 2016
Non-requested quantities to be added to the quantities available for the sub-period from 1 April to 30 June 2016
Količine, za katere niso bili vloženi zahtevki in ki jih je treba dodati razpoložljivim količinam za podobdobje od 1. aprila do 30. junija 2016
establishing a prohibition of fishing for anglerfish in areas VIIIa, VIIIb, VIIId and VIIIe by vessels flying the flag of Belgium
o prepovedi ribolova na morsko spako v območjih VIIIa, VIIIb, VIIId in VIIIe s plovili, ki plujejo pod zastavo Belgije
VIIIa, VIIIb, VIIId and VIIIe
območja VIIIa, VIIIb, VIIId in VIIIe
establishing a prohibition of fishing for hake in areas VIIIa, VIIIb, VIIId and VIIIe by vessels flying the flag of Belgium
o prepovedi ribolova na osliča na območjih VIIIa, VIIIb, VIIId in VIIIe s plovili, ki plujejo pod zastavo Belgije
Commission Implementing Regulation (EU) 2015/1897
Izvedbena uredba Komisije (EU) 2015/1897
amending Commission Regulation (EC) No 2056/2001 as regards the landing obligation
o spremembi Uredbe (ES) št. 2056/2001 glede obveznosti iztovarjanja